Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples. It provides analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. The Production Enhancement segment includes products and services relating to reservoir well completions, perforations, stimulations and production. It provides integrated diagnostic services to evaluate the effectiveness of well completions. The Reservoir Management segment combines and integrates information from reservoir description and production enhancement services to increase production and recovery of oil and gas from its clients' reservoirs.
Industry, Sector and Symbol:
- Sector: Oils/Energy
- Industry: Oil Related Services and Equipment - NEC
- Sub-Industry: N/A
- Symbol: NYSE:CLB
- CUSIP: N/A
- Web: www.corelab.com
Capitalization:- Market Cap: $4.66968 billion
- Outstanding Shares: 44,182,000
Average Prices:- 50 Day Moving Avg: $103.54
- 200 Day Moving Avg: $111.27
- 52 Week Range: $96.30 - $125.83
P/E:- Trailing P/E Ratio: 69.99
- Foreward P/E Ratio: 38.57
- P/E Growth: 1.25
Sales & Book Value:- Annual Revenue: $598.9 million
- Price / Sales: 7.80
- Book Value: $3.38 per share
- Price / Book: 31.27
Dividend:- Annual Dividend: $2.20
- Dividend Yield: 2.1%
Profitability:- EBIDTA: $114.34 million
- Net Margins: 11.10%
- Return on Equity: 43.28%
- Return on Assets: 12.08%
Debt:- Debt-to-Equity Ratio: 1.43%
- Current Ratio: 1.85%
- Quick Ratio: 1.50%
Misc:- Average Volume: 731,910 shs.
- Beta: 1.6
- Short Ratio: 14.53
Frequently Asked Questions for Core Laboratories N.V. (NYSE:CLB)
What is Core Laboratories N.V.'s stock symbol?
Core Laboratories N.V. trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."
How often does Core Laboratories N.V. pay dividends? What is the dividend yield for Core Laboratories N.V.?
Core Laboratories N.V. declared a quarterly dividend on Thursday, July 6th. Investors of record on Monday, July 17th will be paid a dividend of $0.55 per share on Monday, August 14th. This represents a $2.20 dividend on an annualized basis and a yield of 2.08%. The ex-dividend date of this dividend is Thursday, July 13th. View Core Laboratories N.V.'s Dividend History.
How were Core Laboratories N.V.'s earnings last quarter?
Core Laboratories N.V. (NYSE:CLB) announced its quarterly earnings results on Wednesday, July, 20th. The company reported $0.35 earnings per share for the quarter, hitting the Thomson Reuters' consensus estimate of $0.35. The company had revenue of $148.10 million for the quarter, compared to analysts' expectations of $146.37 million. Core Laboratories N.V. had a return on equity of 43.28% and a net margin of 11.10%. The firm's revenue for the quarter was down 27.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.81 EPS. View Core Laboratories N.V.'s Earnings History.
When will Core Laboratories N.V. make its next earnings announcement?
Where is Core Laboratories N.V.'s stock going? Where will Core Laboratories N.V.'s stock price be in 2017?
12 equities research analysts have issued twelve-month price objectives for Core Laboratories N.V.'s stock. Their predictions range from $91.00 to $145.00. On average, they expect Core Laboratories N.V.'s share price to reach $122.78 in the next year. View Analyst Ratings for Core Laboratories N.V..
Who are some of Core Laboratories N.V.'s key competitors?
Some companies that are related to Core Laboratories N.V. include RPC (RES), Antero Midstream GP LP (AMGP), Oceaneering International (OII), John Wood Group PLC (WG), McDermott International (MDR), Frank's International N.V. (FI), Superior Energy Services (SPN), Petrofac Limited (PFC), Forum Energy Technologies (FET), USA Compression Partners, LP (USAC), Exterran Corporation (EXTN), NCS Multistage Holdings (NCSM), Archrock Partners, L.P. (APLP), Helix Energy Solutions Group (HLX), Archrock (AROC), Fairmount Santrol Holdings (FMSA), Newpark Resources (NR) and Flotek Industries (FTK).
Who are Core Laboratories N.V.'s key executives?
Core Laboratories N.V.'s management team includes the folowing people:
- David M. Demshur, Chairman of the Supervisory Board, President, Chief Executive Officer
- Richard L. Bergmark, Chief Financial Officer, Executive Vice President, Member of the Supervisory Board
- Monty L. Davis, Chief Operating Officer, Senior Vice President
- Christopher S. Hill, Vice President, Chief Accounting Officer
- Mark F. Elvig, Vice President, Secretary, General Counsel
- Gwendolyn Y. Schreffler, Vice President, Corporate Development & Investor Relations
- Martha Carnes, Member of the Supervisory Board
- Charles L. Dunlap, Member of the Supervisory Board
- Jan Willem Sodderland, Member of the Supervisory Board
- Michael Straughen, Member of the Supervisory Board
Who owns Core Laboratories N.V. stock?
Core Laboratories N.V.'s stock is owned by a number of of institutional and retail investors. Top institutional shareholders include APG Asset Management N.V. (1.04%), Forsta AP Fonden (0.35%), US Bancorp DE (0.28%), BTIM Corp. (0.17%), Academy Capital Management Inc. TX (0.15%) and Franklin Street Advisors Inc. NC (0.13%). Company insiders that own Core Laboratories N.V. stock include Jan Willem Sodderland, Martha Z Carnes and Michael Straughen. View Institutional Ownership Trends for Core Laboratories N.V..
Who sold Core Laboratories N.V. stock? Who is selling Core Laboratories N.V. stock?
Core Laboratories N.V.'s stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Douglas Lane & Associates LLC, US Bancorp DE, Oregon Public Employees Retirement Fund, BB&T Corp, BTIM Corp., Taylor Wealth Management Partners and Farmers & Merchants Investments Inc.. View Insider Buying and Selling for Core Laboratories N.V..
Who bought Core Laboratories N.V. stock? Who is buying Core Laboratories N.V. stock?
Core Laboratories N.V.'s stock was bought by a variety of institutional investors in the last quarter, including Forsta AP Fonden, Assenagon Asset Management S.A., Mn Services Vermogensbeheer B.V., Franklin Street Advisors Inc. NC, Xact Kapitalforvaltning AB, Eqis Capital Management Inc., B & T Capital Management DBA Alpha Capital Management and Aperio Group LLC. Company insiders that have bought Core Laboratories N.V. stock in the last two years include Jan Willem Sodderland, Martha Z Carnes and Michael Straughen. View Insider Buying and Selling for Core Laboratories N.V..
How do I buy Core Laboratories N.V. stock?
Shares of Core Laboratories N.V. can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Core Laboratories N.V.'s stock price today?
One share of Core Laboratories N.V. stock can currently be purchased for approximately $105.69.
MarketBeat Community Rating for Core Laboratories N.V. (NYSE CLB)MarketBeat's community ratings are surveys of what our community members think about Core Laboratories N.V. and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Core Laboratories N.V. (NYSE:CLB) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 1 Sell Rating, 7 Hold Ratings, 4 Buy Ratings |
| Consensus Rating: | Hold (Score: 2.25) |
| Consensus Price Target: | $122.78 (16.17% upside) |
Analysts' Ratings History for Core Laboratories N.V. (NYSE:CLB)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 6/21/2017 | Morgan Stanley | Reiterated Rating | Overweight | $150.00 -> $130.00 | Low |  |
| 6/17/2017 | Royal Bank Of Canada | Set Price Target | Buy | $145.00 | Low | |
| 4/22/2017 | Scotiabank | Set Price Target | Hold | $136.00 | Low | |
| 4/21/2017 | ABN Amro | Upgrade | Hold | | Low | |
| 4/21/2017 | Loop Capital | Upgrade | Hold -> Buy | $125.00 -> $130.00 | Low | |
| 3/23/2017 | Tudor Pickering | Initiated Coverage | Hold | | Low | |
| 3/11/2017 | Citigroup Inc. | Reiterated Rating | Neutral | $119.00 -> $117.00 | N/A | |
| 12/7/2016 | Stephens | Downgrade | Equal Weight -> Sell | $91.00 | N/A | |
| 12/6/2016 | Guggenheim | Downgrade | Buy -> Neutral | | N/A | |
| 10/22/2016 | Cowen and Company | Reiterated Rating | Market Perform | $105.00 | N/A | |
| 10/5/2016 | DA Davidson | Initiated Coverage | Buy | $136.00 | N/A | |
| 9/1/2016 | Credit Suisse Group | Initiated Coverage | Neutral | $115.00 | N/A | |
| 7/12/2016 | J P Morgan Chase & Co | Downgrade | Neutral -> Underweight | | N/A | |
| 6/13/2016 | KLR Group | Reiterated Rating | Buy | $166.00 -> $180.00 | N/A | |
| 4/23/2016 | Simmons | Reiterated Rating | Hold | $105.00 -> $115.00 | N/A | |
| 3/28/2016 | Howard Weil | Boost Price Target | | $112.00 | N/A | |
| 2/10/2016 | ING Group | Lower Price Target | Hold | $125.00 -> $112.00 | N/A | |
| 2/2/2016 | William Blair | Reiterated Rating | Outperform | | N/A | |
| 1/29/2016 | SunTrust Banks, Inc. | Lower Price Target | Buy | $123.00 -> $109.00 | N/A | |
| 1/29/2016 | Iberia Capital | Lower Price Target | Outperform | $140.00 -> $115.00 | N/A | |
| 1/26/2016 | HSBC Holdings plc | Downgrade | Hold -> Reduce | | N/A | |
| 1/11/2016 | Oppenheimer Holdings, Inc. | Initiated Coverage | Market Perform | | N/A | |
| 9/30/2015 | Sterne Agee CRT | Lower Price Target | Neutral | $113.00 -> $108.00 | N/A | |
(Data available from 7/24/2015 forward)
Earnings History for Core Laboratories N.V. (NYSE:CLB)Earnings History by Quarter for Core Laboratories N.V. (NYSE CLB)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 7/24/2017 | 6/30/2017 | $0.51 | | | | | N/A | |
| 4/19/2017 | 3/31/2017 | $0.39 | $0.42 | $150.44 million | $157.81 million | View | N/A | |
| 1/25/2017 | 12/31/2016 | $0.41 | $0.41 | $145.78 million | $149.54 million | View | N/A | |
| 10/19/2016 | Q316 | $0.38 | $0.38 | $155.72 million | $143.50 million | View | N/A | |
| 7/20/2016 | Q216 | $0.35 | $0.35 | $146.37 million | $148.10 million | View | N/A | |
| 4/20/2016 | Q116 | $0.37 | $0.37 | $161.24 million | $153.65 million | View | N/A | |
| 1/27/2016 | Q415 | $0.65 | $0.65 | $179.48 million | $182.70 million | View | Listen | |
| 10/21/2015 | Q315 | $0.83 | $0.83 | $203.29 million | $197.27 million | View | Listen | |
| 7/22/2015 | Q215 | $0.77 | $0.82 | $195.13 million | $204.00 million | View | Listen | |
| 4/22/2015 | Q115 | $0.85 | $0.86 | $211.82 million | $213.64 million | View | N/A | |
| 1/28/2015 | Q414 | $1.54 | $1.54 | $280.18 million | $278.60 million | View | N/A | |
| 10/22/2014 | Q314 | $1.52 | $1.53 | $284.30 million | $276.14 million | View | Listen | |
| 7/23/2014 | Q214 | $1.35 | $1.35 | $269.70 million | $267.56 million | View | Listen | |
| 4/23/2014 | Q114 | $1.45 | $1.45 | $283.02 million | $262.90 million | View | Listen | |
| 1/30/2014 | Q413 | $1.40 | $1.43 | $278.55 million | $276.30 million | View | Listen | |
| 10/17/2013 | Q313 | $1.34 | $1.36 | $267.21 million | $273.16 million | View | N/A | |
| 7/17/2013 | Q2 2013 | $1.31 | $1.32 | $267.24 million | $263.14 million | View | Listen | |
| 4/17/2013 | Q1 2013 | $1.15 | $1.22 | $260.90 million | $260.90 million | View | Listen | |
| 1/30/2013 | Q4 2012 | $1.13 | $1.17 | $246.49 million | $254.46 million | View | Listen | |
| 10/17/2012 | | $1.10 | $1.13 | | | View | N/A | |
| 7/18/2012 | | $1.16 | $1.16 | | | View | N/A | |
| 4/18/2012 | | $1.07 | $1.06 | | | View | N/A | |
| 2/1/2012 | | $1.08 | $1.09 | | | View | N/A | |
| 10/19/2011 | | $0.99 | $0.93 | | | View | N/A | |
| 4/19/2011 | | $0.75 | $0.77 | | | View | N/A | |
| 2/9/2011 | | $0.81 | $0.84 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Core Laboratories N.V. (NYSE:CLB)2017 EPS Consensus Estimate: $2.62
2018 EPS Consensus Estimate: $3.44
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 3 | $0.39 | $0.81 | $0.53 |
| Q2 2017 | 3 | $0.47 | $0.88 | $0.61 |
| Q3 2017 | 3 | $0.55 | $0.97 | $0.72 |
| Q4 2017 | 3 | $0.54 | $1.03 | $0.76 |
| Q1 2018 | 1 | $0.73 | $0.73 | $0.73 |
| Q2 2018 | 1 | $0.84 | $0.84 | $0.84 |
| Q3 2018 | 1 | $1.00 | $1.00 | $1.00 |
| Q4 2018 | 2 | $0.65 | $1.08 | $0.87 |
(Data provided by Zacks Investment Research)
Current Dividend Information for Core Laboratories N.V. (NYSE:CLB)| Next Dividend: | 8/14/2017 |
| Annual Dividend: | $2.20 |
| Dividend Yield: | 2.08% |
| Dividend Growth: | 19.80% (3 Year Average) |
| Payout Ratio: | 145.70% (Trailing 12 Months of Earnings)
103.29% (Based on This Year's Estimates)
80.29% (Based on Next Year's Estimates)
|
Dividend History by Quarter for Core Laboratories N.V. (NYSE CLB)| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 7/6/2017 | Quarterly | $0.55 | 2.11% | 7/13/2017 | 7/17/2017 | 8/14/2017 |
| 4/19/2017 | quarterly | $0.55 | 1.98% | 4/27/2017 | 4/28/2017 | 5/23/2017 |
| 1/10/2017 | Quarterly | $0.55 | 1.8% | 1/18/2017 | 1/20/2017 | 2/17/2017 |
| 10/11/2016 | Quarterly | $0.55 | 1.95% | 10/19/2016 | 10/21/2016 | 11/22/2016 |
| 7/7/2016 | Quarterly | $0.55 | | 7/14/2016 | 7/18/2016 | 8/15/2016 |
| 4/15/2016 | Quarterly | $0.55 | | 5/2/2016 | 5/4/2016 | 5/24/2016 |
| 1/11/2016 | Quarterly | $0.55 | 2.28% | 1/20/2016 | 1/22/2016 | 2/19/2016 |
| 10/13/2015 | Quarterly | $0.55 | | 10/21/2015 | 10/23/2015 | 11/24/2015 |
| 7/7/2015 | quarterly | $0.55 | 2.02% | 7/15/2015 | 7/17/2015 | 8/17/2015 |
| 1/12/2015 | | $0.55 | | 1/21/2015 | 1/23/2015 | 2/20/2015 |
| 10/6/2014 | quarterly | $0.50 | 1.39% | 10/16/2014 | 10/17/2014 | 11/25/2014 |
| 7/8/2014 | quarterly | $0.50 | | 7/16/2014 | 7/18/2014 | 8/18/2014 |
| 4/14/2014 | quarterly | $0.50 | 1.33% | 4/23/2014 | 4/25/2014 | 5/23/2014 |
| 1/13/2014 | quarterly | $0.50 | 1.05% | 1/22/2014 | 1/24/2014 | 2/21/2014 |
| 10/8/2013 | quarterly | $0.32 | 0.73% | 10/16/2013 | 10/18/2013 | 11/20/2013 |
| 7/9/2013 | quarterly | $0.32 | 0.82% | 7/17/2013 | 7/19/2013 | 8/19/2013 |
| 4/15/2013 | quarterly | $0.32 | 1.01% | 4/24/2013 | 4/26/2013 | 5/24/2013 |
| 1/11/2013 | quarterly | $0.32 | | | 1/22/2013 | 2/22/2013 |
(Data available from 1/1/2013 forward)
Insider Trading and Institutional Ownership History for Core Laboratories N.V. (NYSE:CLB)Insider Ownership Percentage: 1.00%
Insider Trades by Quarter for Core Laboratories N.V. (NYSE:CLB)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 2/1/2017 | Michael Straughen | Director | Buy | 106 | $118.65 | $12,576.90 | |
| 1/30/2017 | Martha Z Carnes | Director | Buy | 200 | $115.20 | $23,040.00 | |
| 2/2/2016 | Jan Willem Sodderland | Director | Buy | 300 | $93.90 | $28,170.00 | |
| 5/12/2015 | Michael C Kearney | Director | Sell | 1,000 | $128.52 | $128,520.00 | |
| 11/17/2014 | Mark F Elvig | VP | Sell | 1,000 | $138.03 | $138,030.00 | |
| 7/28/2014 | Richard L Bergmark | CFO | Buy | 7,000 | $147.31 | $1,031,170.00 | |
| 3/7/2014 | Michael Kearney | Director | Sell | 2,000 | $193.00 | $386,000.00 | |
| 2/14/2014 | Mark Elvig | VP | Sell | 1,500 | $186.64 | $279,960.00 | |
| 10/21/2013 | Monty L Davis | COO | Sell | 5,704 | $197.33 | $1,125,570.32 | |
| 8/7/2013 | Richard Bergmark | CFO | Sell | 20,000 | $149.58 | $2,991,600.00 | |
| 7/25/2013 | Charles Brigham Miller | CAO | Sell | 11,648 | $147.81 | $1,721,690.88 | |
| 7/25/2013 | Monty L Davis | COO | Sell | 5,948 | $149.12 | $886,965.76 | |
(Data available from 1/1/2013 forward)
Headline Trends for Core Laboratories N.V. (NYSE:CLB)
Latest Headlines for Core Laboratories N.V. (NYSE:CLB)
| Source: |
|
| Date | Headline |
|---|
 | Core Laboratories N.V. (CLB) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - July 22 at 12:12 AM |
 | Fracture ID and Core Laboratories Launch the Horizontal Reservoir Characterization Consortium - Midland Basin
finance.yahoo.com - July 20 at 7:06 PM |
| Core Laboratories N.V. (CLB) Scheduled to Post Quarterly Earnings on Monday
www.americanbankingnews.com - July 17 at 8:52 AM |
| Core Laboratories N.V. (CLB) Expected to Announce Quarterly Sales of $169.02 Million
www.americanbankingnews.com - July 15 at 8:15 AM |
| ETFs with exposure to Core Laboratories NV : July 14, 2017
finance.yahoo.com - July 14 at 7:18 PM |
| Core Laboratories N.V. (NYSE:CLB) Expected to Announce Earnings of $0.50 Per Share
www.americanbankingnews.com - July 13 at 2:14 PM |
 | Core Laboratories NV (CLB) Ex-Dividend Date Scheduled for July 13, 2017 - Nasdaq
www.nasdaq.com - July 12 at 5:53 PM |
| Core Laboratories NV breached its 50 day moving average in a Bullish Manner : CLB-US : July 12, 2017
finance.yahoo.com - July 12 at 5:53 PM |
| After Hours Most Active for Jul 11, 2017 : KNX, QQQ, INTC, AABA, BAC, KATE, CY, HLT, CLB, RICE, MU, ODP - Nasdaq
www.nasdaq.com - July 11 at 6:20 PM |
 | Core Laboratories N.V.: The Bear Case From a Bull
www.fool.com - July 10 at 12:55 PM |
| Core Laboratories N.V. (CLB) Rating Increased to Hold at BidaskClub
www.americanbankingnews.com - July 9 at 4:10 PM |
| Core Laboratories N.V. Plans Dividend of $0.55 (CLB)
www.americanbankingnews.com - July 7 at 9:48 PM |
 | Core Lab Announces Q3 2017 Quarterly Dividend - PR Newswire (press release)
www.prnewswire.com - July 7 at 4:33 AM |
 | Knight Transportation (KNX), Core Laboratories (CLB) to Be Added to S&P MidCap 400; SolarEdge (SEDG) to S&P ... - StreetInsider.com
www.streetinsider.com - July 7 at 4:33 AM |
| Core Lab Announces Q3 2017 Quarterly Dividend
finance.yahoo.com - July 6 at 6:28 PM |
| Knight Transportation, Core Laboratories Set to Join S&P MidCap 400; SolarEdge Technologies to Join S&P SmallCap 600
finance.yahoo.com - July 6 at 6:28 PM |
| Core Laboratories' Second Quarter 2017 Webcast At 7:30 A.M. CDT ... - PR Newswire (press release)
www.prnewswire.com - July 5 at 10:59 PM |
| Core Laboratories' Second Quarter 2017 Webcast At 7:30 A.M. CDT / 2:30 P.M. CEST On July 25, 2017
finance.yahoo.com - July 5 at 5:56 PM |
 | Pre-Market Technical Pulse on Oil & Gas Stocks -- Baker Hughes, C&J Energy Services, Core Laboratories, and NOW Inc.
www.bizjournals.com - June 30 at 5:23 PM |
| Pre-Market Technical Pulse on Oil & Gas Stocks -- Baker Hughes ... - PR Newswire (press release)
www.prnewswire.com - June 30 at 5:23 PM |
| Core Laboratories N.V. (CLB) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - June 27 at 12:40 AM |
| Core Laboratories N.V. (CLB) Stock Rating Reaffirmed by Morgan Stanley
www.americanbankingnews.com - June 25 at 1:16 PM |
| Core Laboratories N.V. (CLB) Downgraded to Sell at BidaskClub
www.americanbankingnews.com - June 24 at 7:58 PM |
| Core Laboratories N.V. (CLB) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - June 23 at 12:50 PM |
| Correlation between Nabors Industries and Crude Oil as of June 19
finance.yahoo.com - June 22 at 11:07 AM |
| EnerCom The Oil & Gas Conference(R): 2017 Registrations Outpacing 2016
finance.yahoo.com - June 21 at 5:30 PM |
| Better Buy: Core Laboratories NV vs. Frank's International NV - Motley Fool
www.fool.com - June 19 at 2:20 PM |
| Better Buy: Core Laboratories N.V. vs. Frank's International N.V.
finance.yahoo.com - June 19 at 2:20 PM |
| Core Laboratories N.V. (CLB) Expected to Announce Earnings of $0.50 Per Share
www.americanbankingnews.com - June 19 at 2:04 PM |
| Core Laboratories N.V. (CLB) PT Set at $145.00 by Royal Bank Of Canada
www.americanbankingnews.com - June 19 at 12:38 AM |
| Core Laboratories N.V. (CLB) Stock Rating Upgraded by BidaskClub
www.americanbankingnews.com - June 18 at 12:38 PM |
| What’s the Correlation between Halliburton Stock and Crude Oil?
finance.yahoo.com - June 15 at 6:07 PM |
| Halliburton’s Valuation Compared to Its Peers
finance.yahoo.com - June 14 at 5:10 PM |
| Here's Why the Best Is Yet to Come for Core Laboratories N.V.
www.fool.com - June 12 at 1:46 PM |
| Core Laboratories N.V. (CLB) Rating Increased to Buy at Zacks Investment Research
www.americanbankingnews.com - June 12 at 11:10 AM |
| Core Laboratories (CLB) Rating Lowered to Sell at ValuEngine
www.americanbankingnews.com - June 6 at 10:26 PM |
 | Core Laboratories N.V. (CLB) Presents At Credit Suisse 2017 Global Energy Conference - Slideshow
seekingalpha.com - June 6 at 4:31 PM |
| What Return On Gross Invested Capital Is And Why It Matters
finance.yahoo.com - June 2 at 5:49 PM |
| Core Laboratories (CLB) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - May 31 at 12:39 AM |
| Core Laboratories (CLB) Expected to Post Quarterly Sales of $169.02 Million
www.americanbankingnews.com - May 26 at 4:08 PM |
| Why Is Core Laboratories (CLB) Down 6.8% Since the Last Earnings Report? - Nasdaq
www.nasdaq.com - May 24 at 4:11 PM |
| Core Laboratories (CLB) Expected to Post Earnings of $0.50 Per Share
www.americanbankingnews.com - May 24 at 1:02 PM |
| What Would Get Oil Back to $100 a Barrel?
finance.yahoo.com - May 24 at 12:45 PM |
| Why Is Core Laboratories (CLB) Down 6.8% Since the Last Earnings Report?
finance.yahoo.com - May 22 at 12:35 PM |
| Core Laboratories Stock Tumbles as Billionaire Shares Bear Case - Motley Fool
www.fool.com - May 16 at 4:22 PM |
| Core Laboratories Stock Tumbles as Billionaire Shares Bear Case
www.fool.com - May 15 at 4:25 PM |
| Here's What Would Need to Happen for Oil Prices to Get Back to $100
finance.yahoo.com - May 15 at 1:29 PM |
| Einhorn at Sohn Investment Conference: Short Core Laboratories
finance.yahoo.com - May 11 at 4:57 PM |
 | SOHN Spotlight: Short Core Labs, Greenlight's Einhorn Says - Barron's
www.barrons.com - May 10 at 8:19 AM |
| ETFs with exposure to Core Laboratories NV : May 9, 2017
finance.yahoo.com - May 9 at 9:22 PM |
Core Laboratories N.V. (CLB) Chart for Monday, July, 24, 2017
